🔎 Trials Near Me

መነሻ › Metastatic Cancer › Ohio › Cincinnati

በCincinnati፣ OH ለMetastatic Cancer የሚደረጉ ክሊኒካዊ ጥናቶች

ለMetastatic Cancer የሚደረጉ 20 ጥናቶች በCincinnati እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Good Samaritan Hospital - Cincinnati, Cincinnati
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05564377

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Oncology Hematology Care - Eastgate, Cincinnati
  • Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • እና 1 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07222566

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Cincinnati
  • Research Site, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Cincinnati Medical Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Saint Elizabeth Medical Center Edgewood, Edgewood · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Cincinnati Medical Center, Cincinnati
  • Oncology Hematology Care Inc, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Edgewood · 8 ማይል ርቀት
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07647328

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • USO - Oncology Hematology Care, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06119581

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • St. Elizabeth Healthcare, Edgewood · 8 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Cincinnati Medical Center (UCMC), Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT05614739

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Oncology Hematology Care Primary, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ጁላይ 2026 · NCT07044336

A Study of PYX-201 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of Cincinnati Medical Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT05720117

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The Christ Hospital, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Christ Hospital Cancer Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT05379985

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Cincinnati Medical Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሜይ 2026 · NCT06416007

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Cincinnati
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The Christ Hospital Cancer Center, Cincinnati
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2025 · NCT05808634

በሌሎች ከተሞች ለMetastatic Cancer የሚደረጉ ጥናቶች

በCincinnati ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።